Ron Cohen, President and CEO, Acorda Therapeutics, Inc.

Type:

Video

Dr. Cohen discusses the plight of today’s emerging biotech companies, and how the federal government can best support innovation within the industry so that the U.S. remains globally competitive. Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with MS, spinal cord injury and other neurological conditions.

September 12, 2011 2012 World Congress on Industrial Biotechnology and Bioprocessing	September 12, 2011 Podcast: Margaret Anderson, Executive Director of FasterCures	September 9, 2011 Contagion: How Would We Respond to a Pandemic?	September 9, 2011 Eva Jack, Chief Business Officer at Pulmatrix, on the Promise of Biotech
August 15, 2011 Dr. Steven Perrin, CEO, CSO and Vice Chairman, ALS Therapy Development Institute	August 11, 2011 When RARE is not so RARE!	June 30, 2011 2012 Flash Mob Event - 2011 BIO International Convention	June 30, 2011 Humanitarian Award Winner Dr. Paul Offit